The Impact of Pfizer’s Price Increases for Xeljanz on Pharmaceutical Innovation. Girvan, G. October, 2022.
The Impact of Pfizer’s Price Increases for Xeljanz on Pharmaceutical Innovation [link]Paper  abstract   bibtex   
Since 2014, Pfizer has garnered $5.6 billion from price increases on rheumatoid arthritis drug Xeljanz.
@misc{girvan_impact_2022,
	title = {The {Impact} of {Pfizer}’s {Price} {Increases} for {Xeljanz} on {Pharmaceutical} {Innovation}},
	url = {https://freopp.org/the-impact-of-pfizers-price-increases-for-xeljanz-on-pharmaceutical-innovation-a22c8d590bf5},
	abstract = {Since 2014, Pfizer has garnered \$5.6 billion from price increases on rheumatoid arthritis drug Xeljanz.},
	language = {en},
	urldate = {2024-04-25},
	journal = {Medium},
	author = {Girvan, Gregg},
	month = oct,
	year = {2022},
	keywords = {Pfizer, Xeljanz},
}

Downloads: 0